googlefd16b42746daa692.html

Twitter 

 
Information for patients

Information for patients

Information for providers

Information for providers

Information for researchers

Information for researchers

 

See you in Athens!!

Feature articles

The ESCMID study group for Infections in Compromised Hosts have just published a series of consensus documents on the safety of a number of novel cancer therapies (including small molecule inhibitors and immune checkpoint inhibitors) from an Infectious Diseases perspective.

Head over to our info for providers page for the full list.


googlefd16b42746daa692.html